Proteomics approaches to uncover the repertoire of circulating biomarkers for breast cancer

被引：34

作者：

Shin, BK ^{[1
]}

Wang, H ^{[1
]}

Hanash, S ^{[1
]}

机构：

[1] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA

来源：

JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA | 2002年 / 7卷 / 04期

关键词：

proteomics; cancer biomarker; breast cancer;

D O I：

10.1023/A:1024038132381

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

There is substantial interest in applying proteomics to cancer biomarker discovery. Proteomics is particularly suited for profiling biological fluids and uncovering circulating markers and is currently being applied to the identification of novel biomarkers for breast cancer. Novel proteomic approaches include direct profiling of serum using mass spectrometry, application of a variety of strategies to harness immunity for cancer diagnosis, protein tagging to capture subproteomes rich in diagnostic markers, the use of protein microarrays, and the use of multidimensional liquid protein separation technologies for comprehensive profiling of serum and other biological fluids. It is likely that the application of a wide range of proteomics tools to breast cancer will yield a panel of markers that have utility for breast cancer diagnosis.

引用

页码：407 / 413

页数：7

共 27 条

[1]

Ardekani Ali M, 2002, Expert Rev Mol Diagn, V2, P312, DOI 10.1586/14737159.2.4.312

[2]

Barnea E, 2002, EUR J IMMUNOL, V32, P213, DOI 10.1002/1521-4141(200201)32:1<213::AID-IMMU213>3.3.CO

[3]

2-#

[4] A method for global protein expression and antibody screening on high-density filters of an arrayed cDNA library [J].